Lexpos News

Pharmacy owners and their teams (including locums) are asked to consider participating in an evaluation of the Community Pharmacy Contractual Framework (CPCF) 2019-24 clinical services. NHS England has commissioned RAND Europe to conduct an independent evaluation of clinical services under the CPCF (also known as the ‘pharmacy contract’). The evaluation aims to gather input from [...]

The post Call for volunteers – Evaluation of the CPCF 2019-2024 clinical services appeared first on Community Pharmacy England.

NHS England has announced a new expression of interest (EOI) process for pharmacy owners that wish to take part in the COVID-19 Vaccination Service from a location away from their pharmacy and are able to assist with the provision of further fixed sites services and/or outreach vaccination services. Each NHS England regional teams will determine what services [...]

The post NHSE opens EOI process for additional capacity for C-19 vacs service appeared first on Community Pharmacy England.

Yesterday, new Secretary of State for Health and Social Care Wes Streeting announced plans for his Department to expand its focus to boost economic growth, which includes an objective to cut waiting times and improve public health. This is in line with Labour’s health mission, which Community Pharmacy England has been considering for some time. [...]

The post Health Secretary announces mission to improve the health of the nation appeared first on Community Pharmacy England.

The Incident Reporting Approved Particulars were due to be updated on NHS England’s website this week, but we understand that this has now been delayed until the end of July. This is a change to the timing announced in last week’s Primary Care Bulletin. The clinical governance requirements of the community pharmacy contractual framework (CPCF) [...]

The post Updated Incident Reporting Approved Particulars appeared first on Community Pharmacy England.

Class 4 Medicines Defect Information: Propantheline Tablets 15mg (Genesis Pharmaceuticals livery (Chelonia Healthcare Limited)) Drug alert number: EL (24)A/27 Date issued: 9 July 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Propantheline Tablets 15mg (Genesis Pharmaceuticals livery (Chelonia Healthcare Limited)) Company name: Chelonia Healthcare Limited [...]

The post MHRA Class 4 Medicines Defect Information: Propantheline Tablets 15mg (Genesis Pharmaceuticals livery (Chelonia Healthcare Limited)) appeared first on Community Pharmacy England.